A hemolytic anti‐LKE associated with a rare LKE‐negative, “weak P” red blood cell phenotype: alloanti‐LKE and alloanti‐P recognize galactosylgloboside and monosialogalactosylgloboside (LKE) antigens
dc.contributor.author | Cooling, Laura | en_US |
dc.contributor.author | Dake, Louann R. | en_US |
dc.contributor.author | Haverty, Donna | en_US |
dc.contributor.author | Mullis, Nancy | en_US |
dc.contributor.author | Ellis, Susie | en_US |
dc.contributor.author | Shayman, James | en_US |
dc.contributor.author | Judd, W. John | en_US |
dc.date.accessioned | 2015-02-19T15:40:37Z | |
dc.date.available | 2016-03-02T19:36:55Z | en |
dc.date.issued | 2015-01 | en_US |
dc.identifier.citation | Cooling, Laura; Dake, Louann R.; Haverty, Donna; Mullis, Nancy; Ellis, Susie; Shayman, James; Judd, W. John (2015). "A hemolytic anti‐LKE associated with a rare LKE‐negative, “weak P” red blood cell phenotype: alloanti‐LKE and alloanti‐P recognize galactosylgloboside and monosialogalactosylgloboside (LKE) antigens." Transfusion (1): 115-128. | en_US |
dc.identifier.issn | 0041-1132 | en_US |
dc.identifier.issn | 1537-2995 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/110583 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.publisher | American Association of Blood Banks | en_US |
dc.title | A hemolytic anti‐LKE associated with a rare LKE‐negative, “weak P” red blood cell phenotype: alloanti‐LKE and alloanti‐P recognize galactosylgloboside and monosialogalactosylgloboside (LKE) antigens | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/110583/1/trf12772.pdf | |
dc.identifier.doi | 10.1111/trf.12772 | en_US |
dc.identifier.source | Transfusion | en_US |
dc.identifier.citedreference | Stroud MR, Stapleton AE, Levery SB. The P histo‐blood group‐related glycosphingolipid sialosyl galactosyl globoside as a preferred binding receptor for uropathogenic Escherichia coli: isolation and structural characterization from human kidney. Biochemistry 1998; 37: 17420 ‐ 17428. | en_US |
dc.identifier.citedreference | Cooling L, Hwang D. Monoclonal antibody B2, a marker of neuroendocrine sympathoadrenal precursors, recognizes the Luke (LKE) antigen. Transfusion 2005; 45: 709 ‐ 716. | en_US |
dc.identifier.citedreference | Stapleton AE, Stroud MR, Hakomori S, et al. The globoseries glycosphingolipid sialosyl galactosyl globoside is found in urinary tract tissues and is a preferred receptor in vitro for uropathogenic Escherichia coli expressing pap‐encoded adhesions. Infect Immun 1998; 66: 3856 ‐ 3861. | en_US |
dc.identifier.citedreference | Karr JF, Nowicki BJ, Truong DL, et al. Pap‐2‐encoded fimbriae adhere to the P blood group‐related glycosphingolipid stage‐specific embryonic antigen 4 in the human kidney. Infect Immun 1990; 58: 4055 ‐ 4062. | en_US |
dc.identifier.citedreference | Ito A, Saito S, Masuko T, et al. Monoclonal antibody (5F3) defining renal cell carcinoma‐associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues. Glyconj J 2001; 18: 475 ‐ 485. | en_US |
dc.identifier.citedreference | Saito S, Levery SB, Salyan MEK, et al. Common tetrasaccharide epitope NeuAcα2‐3Galβ1‐3(NeuAcα2‐6)GalNAc, presented by different carrier glycosylceramides or O‐linked peptides, is recognized by different antibodies and ligands having distinct specificities. J Biol Chem 1994; 269: 5644 ‐ 5652. | en_US |
dc.identifier.citedreference | Gillard BK, Jones MA, Marcus DM. Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells. Arch Biochem Biophys 1987; 256: 435 ‐ 445. | en_US |
dc.identifier.citedreference | Cooling LL, Zhang D, Koerner TA. Human platelets express gangliosides with LKE activity and ABH blood group activity. Transfusion 2001; 41: 504 ‐ 516. | en_US |
dc.identifier.citedreference | Steelant WF, Kawakami Y, Ito A, et al. Monosialyl‐Gb5 organized with cSrc and FAK in GEM of human breast carcinoma MCF‐7 cells defines their invasive properties. FEBS Lett 2002; 531: 93 ‐ 98. | en_US |
dc.identifier.citedreference | Draper JS, Pigott C, Thomson JA, et al. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 2002; 200: 249 ‐ 258. | en_US |
dc.identifier.citedreference | Lawrie CH, Marafioti T, Hatton CSR, et al. Cancer‐associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling. Int J Cancer 2006; 118: 3161 ‐ 3166. | en_US |
dc.identifier.citedreference | Kalisiak A, Minniti JG, Oosterwijk E, et al. Neutral glycosphingolipid expression in B‐cell neoplasm. Int J Cancer 1991; 49: 837 ‐ 845. | en_US |
dc.identifier.citedreference | O'Boyle KP, Freeman K, Kalisiak A, et al. Patterns of ganglioside expression in B cell cell neoplasms. Leuk Lymphoma 1996; 21: 255 ‐ 266. | en_US |
dc.identifier.citedreference | Meyer zum Buschenfelde C, Feuerstacke Y, Gotze KS, et al. GM1 expression of non‐Hodgkin's lymphoma determines susceptibility to rituximab treatment. Cancer Res 2008; 68: 5414 ‐ 5422. | en_US |
dc.identifier.citedreference | Noguchi R, Shinomiya N, Nagai K, et al. Induction of suppressor T cells by anti‐globoside antibodies in cancer sera. Jpn J Clin Oncol 1983; 13: 335 ‐ 342. | en_US |
dc.identifier.citedreference | Smorodin EP, Kurtenkov OA, Sergeyev BL, et al. The relation of serum anti‐(βGalNAc) and para‐Forssman disaccharide IgG levels to the progression and histological grading of gastrointestinal cancer. Exp Oncol 2007; 29: 61 ‐ 66. | en_US |
dc.identifier.citedreference | Wang C‐C, Huang Y‐L, Ren C‐T, et al. Glycan microarray of globo‐H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci U S A 2008; 105: 11661 ‐ 11666. | en_US |
dc.identifier.citedreference | Schrump DS, Furukawa K, Yamaguchi H, et al. Recognition of galactosylgloboside derived from patients with primary lung cancer. Proc Natl Acad Sci U S A 1988; 85: 4441 ‐ 4445. | en_US |
dc.identifier.citedreference | Jacob F, Goldstein DR, Bovin NV, et al. Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. Int J Cancer 2011; 130: 138 ‐ 146. | en_US |
dc.identifier.citedreference | Hansson GC, Wazniowska K, Rock JA, et al. The glycosphingolipid composition of the placenta of a blood group P fetus deliverd by a blood group P 1 k woman and analysis of the anti‐globoside antibodies in maternal serum. Arch Biochem Biophys 1988; 260: 168 ‐ 176. | en_US |
dc.identifier.citedreference | Kannagi R, Cochran NA, Ishigami F, et al. Stage‐specific embryonic antigens (SSEA‐3 and ‐4) are epitopes of a unique globo‐series ganglioside isolated from human teratocarcinoma cells. EMBO J 1983; 2: 2355 ‐ 2361. | en_US |
dc.identifier.citedreference | Tippett P, Andrews P, Knowles BB, et al. Red cell antigens P (globoside) and Luke: identification by monoclonal antibodies defining the murine stage‐specific embryonic antigens −3 and ‐4 (SSEA‐3 and SSEA‐4). Vox Sang 1986; 51: 53 ‐ 56. | en_US |
dc.identifier.citedreference | Tippet P. Contributions of monoclonal antibodies to understanding one new and some old blood group systems. Arlington (VA): American Association of Blood Banks; 1986. | en_US |
dc.identifier.citedreference | Cooling L, Kelley K. Inverse expression of P k and Luke blood group antigens on human RBCs. Transfusion 2001; 41: 898 ‐ 907. | en_US |
dc.identifier.citedreference | Tippett P, Sanger R, Race RR, et al. An agglutinin associated with the P and ABO blood group systems. Vox Sang 1965; 10: 269 ‐ 280. | en_US |
dc.identifier.citedreference | Moller B, Jorgensen J. Phenotype frequency of LKE in the Danish population. Hum Hered 1988; 38: 375 ‐ 377. | en_US |
dc.identifier.citedreference | Bruce M, Watt A, Gabra GS, et al. LKE red cell antigen and its relationship to P 1 and P k: serological study of a large family. Vox Sang 1988; 33: 237 ‐ 240. | en_US |
dc.identifier.citedreference | Kundu SK, Evans A, Rizvi J, et al. A new P k phenotype in the P blood group system. J Immunogenet 1980; 7: 431 ‐ 439. | en_US |
dc.identifier.citedreference | Stapleton A, Nudelman E, Clausen H, et al. Binding of uropathogenic E. coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo‐blood group secretor status. J Clin Invest 1992; 90: 965 ‐ 972. | en_US |
dc.identifier.citedreference | Race RR, Sanger R. Blood groups in man. 6th ed. Oxford: Blackwell Scientific Publications; 1965. | en_US |
dc.identifier.citedreference | Kundu SK, Steane SM, Bloom JEC, et al. Abnormal glycolipid composition of erythrocytes with a weak P phenotype. Vox Sang 1978; 35: 160 ‐ 167. | en_US |
dc.identifier.citedreference | Roback JD, editor. Technical manual. 17th ed. Bethesda (MD): American Association of Blood Banks; 2011. | en_US |
dc.identifier.citedreference | Judd WJ, Johnson ST, Storry JR, editors. Judd's methods in immunohematology. 3rd ed. Bethseda (MD): American Association of Blood Banks Press; 2008. | en_US |
dc.identifier.citedreference | Kannagi R, Levery SB, Ishigami F, et al. New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage‐specific embryonic antigen 3. J Biol Chem 1983; 258: 8934 ‐ 8942. | en_US |
dc.identifier.citedreference | Fenderson BA, Nichols EJ, Clausen H, et al. A monoclonal antibody defining a binary N‐acetyl‐lactosaminyl structure in lactoisooctaosyl ceramide. Mol Immunol 1986; 23: 747 ‐ 754. | en_US |
dc.identifier.citedreference | Clegg S. Cloning of genes determining the production of mannose‐resistant fimbriae in a uropathogenic strain of Escherichia coli belonging to serogroup O6. Infect Immun 1985; 38: 739 ‐ 744. | en_US |
dc.identifier.citedreference | Serum, Cells and Rare Fluids Exchange (SCARF). [cited 2013 Jan 30]. Available from: http://scarfex.jove.prohosting.com/contact.html | en_US |
dc.identifier.citedreference | Cooling L. A new look at an old case: an auto‐anti‐P with pseudo‐LKE activity. Int J Blood Transfus Immunohematol 2013; 2: 11 ‐ 21. | en_US |
dc.identifier.citedreference | Marsh WL. Scoring of hemagglutination reactions. Transfusion 1872; 12: 352 ‐ 353. | en_US |
dc.identifier.citedreference | Judd WJ, Cooling L. Novel application of the gel test: detection of microbial‐induced hemagglutination. Vox Sang 2004; 87 ( S ): S17. | en_US |
dc.identifier.citedreference | Ledeen RW, Yu RK. Gangliosides: structure, isolation and analysis. In: Ginsberg V, editor. Methods in enzymology, vol. 83. New York: Academic Press; 1982. p. 139 ‐ 191. | en_US |
dc.identifier.citedreference | Schnaar RL, Needham LK. Thin layer chromatography of glycosphingolipids. In: Lennarz WJ, Hart GW, editors. Methods in enzymology, vol. 230. New York: Academic Press; 1994. p. 371 ‐ 389. | en_US |
dc.identifier.citedreference | Cooling LLW, Zhang D‐S, Naides SJ, et al. Glycosphingolipid expression in acute nonlymphocytic leukemia: common expression of shiga toxin and parvovirus B19 receptors on early myeloblasts. Blood 2003; 101: 711 ‐ 721. | en_US |
dc.identifier.citedreference | Cooling LL, Zhang DS, Walker KW, et al. Detection in human blood platelets of sialyl Lewis X gangliosides: potential ligands for CD62 and other selectins. Glycobiology 1995; 5: 571 ‐ 581. | en_US |
dc.identifier.citedreference | Kundu SK, Suzuki A, Sabo B, et al. Erythrocyte glycosphingolipids of four siblings with the rare blood group p phenotype and their parents. J Immunogenet 1981; 8: 357 ‐ 365. | en_US |
dc.identifier.citedreference | Yiu SCK, Lingwood CA. Polyisobutylmethacrylate modifies glycolipid binding specificity of verotoxin 1 in thin‐layer chromatogram overlay procedures. Anal Biochem 1992; 202: 188 ‐ 192. | en_US |
dc.identifier.citedreference | Gallegos KM, Conrady DG, Karve SS, et al. Shiga toxin binding to glycolipids and glycans. Plos ONE 2012; 7: e30368 ‐ 10. | en_US |
dc.identifier.citedreference | Flechter KS, Bremer IG, Schwarting GA. P blood group regulation of glycosphingolipid levels in human erythrocytes. J Biol Chem 1979; 254: 11196 ‐ 11198. | en_US |
dc.identifier.citedreference | Bierbach E, Yu RK. Multi‐enzyme kinetic analysis of glycolipid biosynthesis. Biochim Biophys Acta 1999; 1432: 113 ‐ 124. | en_US |
dc.identifier.citedreference | Kannagi R, Papyannopoulou T, Nakamoto B, et al. Carbohydrate antigen profiles of human erythroleukemia cell lines HEL and K562. Blood 1983; 62: 1230 ‐ 1241. | en_US |
dc.identifier.citedreference | Watanabe K, Powell ME, Hakomori S‐I. Isolation and characterization of gangliosides with a new sialosyl linkage and core structures. J Biol Chem 1979; 254: 8223 ‐ 8229. | en_US |
dc.identifier.citedreference | Muthing J, Spanbroek R, Peter‐Katalinic J, et al. Isolation and structural characterization of fucosylated gangliosides with linear poly‐N‐acetyllactosaminyl chains from human granulocytes. Glycobiology 1996; 6: 147 ‐ 156. | en_US |
dc.identifier.citedreference | Katagiri YU, Ohmi K, Katagiri C, et al. Prominent immunogenicity of monosialosyl galactosylgloboside, carrying a stage‐specific embryonic antigen‐4 (SSEA‐4) epitope in the ACHN human renal tubular cell line—a simple method for producing monoclonal antibodies against detergent‐insoluble microdomains/raft. Glyconj J 2001; 18: 347 ‐ 353. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.